PDCD1 and neoplasm: Furthermore, mice with VTN-overexpressed tumors treated with anti-PD1 agents showed a considerable slowdown in tumor growth compared to those receiving anti-PD1 treatment or VTN overexpression independently (Figures 6C-E).